Paradromics, Inc.
Paradromics is developing a brain-computer interface platform to translate neural signals into treatments for brain-related illnesses, enhancing communication and sensory-motor functions through advanced AI algorithms. The company focuses on clinical applications for conditions like ALS, spinal cord injuries, and stroke, aiming to revolutionize neurotechnology and mental health treatments.
Paradromics develops breakthrough brain–computer interface (BCI) technology to restore communication and independence for people with severe paralysis from ALS, stroke, and spinal cord injury. The company is building high‑bandwidth, implantable neural interfaces that combine advanced microelectronics, electrode arrays, and decoding software to translate brain signals into control of communication and assistive systems. Paradromics is focused on clinical translation—working with clinicians, running trials, and pursuing regulatory approval—to deliver safe, reliable neuroprosthetic solutions for patients who have lost voluntary motor control.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Paradromics, Inc..
Paradromics, Inc. didn’t post a salary, so this is our estimate from similar listings.
4% below the average for this role
Neural Interface Software Engineer, Brain-Computer Interfaces
FUTRUE
Teaching Track Faculty Position in Neurotechnology (Assistant Professor)
Carnegie Mellon University
Postdoctoral Fellow
NationalunP2
Director of Neurotechnology Innovation Center at Rutgers Brain Health Institute
Rutgers University
Assistant Professor
Princeton University
(Junior) Engineer – BCI Probe & Electrode Design
FUTRUE